ResApp Health (ASX:RAP) Share Price and News

Market Cap (26-Sep) $176,237,888 (1,192nd)	Close (28-Sep) $0.205 0 (0%)	Volume (28-Sep) 0	Shortsold (21-Sep) 297,501 (0.03%) (573rd)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.009

	Subject
	RAP RAP Ann: Removal from Official List
	1 (current) 2 3
	RAP RAP Ann: Scheme of Arrangement has been Implemented
	RAP RAP Ann: Ceasing to be a substantial holder
	RAP RAP Ann: Becoming a substantial holder
	RAP RAP Ann: Notification of cessation of securities - RAP
	RAP RAP Ann: Ceasing to be a substantial holder
	RAP RAP Ann: Suspension from Official Quotation
	RAP RAP Ann: Scheme of Arrangement becomes effective
	RAP RAP Ann: Scheme of Arrangement - Court Approval
	RAP RAP Ann: Becoming a substantial holder
	RAP RAP Ann: Results of Scheme Meeting
	RAP RAP Ann: Scheme Meeting - Chairman's Address & Presentation
	RAP RAP Ann: Becoming a substantial holder
	RAP RAP Ann: Appendix 4G
	RAP RAP Ann: Corporate Governance Statement
	RAP RAP Ann: Appendix 4E and Annual Report
	RAP RAP Ann: Dispatch of Second Supplementary Scheme Booklet
	RAP RAP Ann: Second Supplementary Scheme Booklet
	RAP RAP Ann: Correction to ASX announcement
	RAP RAP Ann: Adjournment of Scheme Meeting to a date to be determined
	RAP RAP Ann: Best and Final Confirmation and Bridging Loan
	RAP RAP Ann: Dispatch of Supplementary Scheme Booklet
	RAP RAP Ann: Pfizer raises scheme consideration to A$0.208 per share
	RAP RAP Ann: Correction to ASX announcement
	RAP RAP Ann: Entry into amended and restated Scheme Implementation Deed
	RAP RAP Ann: Investor Conference Call Notification
	RAP RAP Ann: Quarterly Activities Report and Appendix 4C
	RAP RAP Ann: Quarterly Results and Investor Conference Call Notification
	RAP RAP Ann: Study shows efficacy of ResAppDx use with masks
	RAP RAP Ann: Dispatch of Scheme Booklet
	RAP RAP Ann: Clarification - Scheme Booklet registered with ASIC
	RAP RAP Ann: Scheme Update - ACCC condition precedent satisfied
	RAP RAP Ann: Scheme Booklet registered with ASIC
	RAP RAP Ann: Results of First Court Hearing
	RAP RAP Ann: Medgate Licence Agreement Clarification Announcement
	RAP RAP Ann: Medgate extends licence agreement and plans to expand use
	RAP RAP Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
	RAP RAP Ann: Cough detection patent granted in Australia and Japan
	RAP RAP Ann: Scheme Update
	RAP RAP Ann: ResApp to present at Gold Coast Investment Showcase
	RAP RAP Ann: Results from Data Confirmation Study
	RAP RAP Ann: Trading Halt
	RAP RAP Ann: Investor Webinar
	RAP RAP Ann: Notification of cessation of securities - RAP
	RAP RAP Ann: Application for quotation of securities - RAP
	RAP RAP Ann: Notification of cessation of securities - RAP
	RAP RAP Ann: Reinstatement to Official Quotation
	RAP RAP Ann: Increased Scheme Consideration from Pfizer
	RAP RAP Ann: Voluntary Suspension Extension
	RAP RAP Ann: Voluntary Suspension Extension

Similar Companies

4DMedical

4DX

Alcidion Group

ALC

Cogstate

CGS

ImExHS

IME

Mach7 Technologies

M7T

MedAdvisor

MDR

PainChek

PCK

PKS Holdings

PKS

Pro Medicus

PME

End of Day Prices

Date	Close	Volume	Change
26-Sep	$0.21	0	0.00 (0.00%)
23-Sep	$0.21	0	0.00 (0.00%)
21-Sep	$0.21	0	0.00 (0.00%)
20-Sep	$0.21	0	0.00 (0.00%)
19-Sep	$0.21	0	0.00 (0.00%)
16-Sep	$0.21	0	0.00 (0.00%)
15-Sep	$0.21	2,715,724	-0.01 (2.38%)
14-Sep	$0.21	4,737,693	+0.01 (2.44%)
13-Sep	$0.21	2,870,267	0.00 (0.00%)
12-Sep	$0.21	13,438,734	0.00 (0.00%)
09-Sep	$0.21	6,140,713	0.00 (0.00%)
08-Sep	$0.21	6,700,467	0.00 (0.00%)
07-Sep	$0.21	36,730,379	0.00 (0.00%)
06-Sep	$0.21	16,491,638	+0.00 (2.50%)
05-Sep	$0.20	24,510,980	0.00 (0.00%)
2 up, 1 down, and 12 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
1 July 2025 at 1:30am

High -	Low -	Trades -	Turnover $0	Volume 0
1 July 2025 at 1:30am

ResApp Health Health Care

$0.205 (0%)

$0.205 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices